IP Library Patent Application 15173505
Patent Application
App. No. 15/173,505

METHODS, SYSTEMS AND DEVICES FOR TREATING ORTHOSTATIC INTOLERANCE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/173,505
Abstract

Provided is a method of treating orthostatic intolerance in a patient. The method comprises selecting a patient suffering from orthostatic intolerance and creating a flow pathway between a first vascular location and a second vascular location. The first vascular location comprises a source of arterial blood and the second vascular location comprises a source of venous blood. Systems and devices for creating a flow pathway are also provided.

Claims (27)

1 . A method of treating orthostatic intolerance in a patient, comprising:

selecting a patient exhibiting orthostatic intolerance; and

creating a flow pathway between a first vascular location and a second vascular location;

wherein the first vascular location comprises a source of arterial blood;

wherein the second vascular location comprises a source of venous blood; and

wherein the method is constructed and arranged to treat orthostatic intolerance.

2 .- 164 . (canceled)

165 . The method according to claim 1 , wherein the method is constructed and arranged to treat a disease or disorder selected from the group consisting of: orthostatic hypotension; orthostatic hypotension with hypertension; postural orthostatic tachycardia syndrome; and combinations thereof.

166 . The method according to claim 1 , wherein the method is further constructed and arranged to increase the flow of blood to the right side of the heart.

167 . The method according to claim 166 , wherein the increased flow of blood to the right side of the heart increases cardiac output.

168 . The method according to claim 1 , wherein the method is further constructed and arranged to increase cardiac output.

169 . The method according to claim 1 , wherein the method is further constructed and arranged to reduce arterial hypertension.

170 . The method according to claim 1 , wherein the method is further constructed and arranged to treat a patient disease or disorder selected from the group consisting of: hypertension; arterial hypertension; chronic obstructive pulmonary disease; congestive heart failure; lung fibrosis; adult respiratory distress syndrome; lymphangioleiomyomatosis; pulmonary hypertension; sleep apnea; sleep apnea due to hypoxemia; sleep apnea due to hypertension; and combinations thereof.

171 . The method according to claim 1 , wherein the method is further constructed and arranged to cause a physiologic change in the patient selected from the group consisting of: increased oxygen delivery by the arterial system; increased blood volume; increased proportion of blood flow to the descending aorta; increased blood flow to the kidneys; increased blood flow outside the kidneys; increased cardiac output; and combinations thereof.

172 . The method according to claim 1 , wherein creating the flow pathway comprises a procedure selected from the group consisting of: dilating tissue proximate the flow pathway with a balloon; applying energy to tissue proximate the flow pathway such as RF energy applied to tissue; and combinations thereof.

173 . The method according to claim 1 , wherein the flow pathway comprises a flow rate of at least 400 ml/min.

174 . The method according to claim 1 , wherein the first vascular location comprises an artery selected from the group consisting of: aorta; axillary; brachial; ulnar; radial; profundal; femoral; iliac; popliteal; and carotid.

175 . The method according to claim 174 , wherein the second vascular location comprises a vein.

176 . The method according to claim 1 , wherein the second vascular location comprises a vein selected from the group consisting of: inferior vena cava; saphenous; femoral; iliac; popliteal; brachial; basilic; cephalic; medial forearm; medial cubital; axillary; and jugular.

177 . The method according to claim 176 , wherein the first vascular location comprises an artery.

178 . The method according to claim 1 , wherein the first vascular location comprises a chamber of the heart.

179 . The method according to claim 1 , wherein the flow pathway comprises a diameter of at least 2.5 mm.

180 . The method according to claim 179 , wherein the flow pathway comprises a diameter of at least 3.0 mm.

181 . The method according to claim 179 , wherein the flow pathway comprises a diameter of less than or equal to 6.0 mm.

182 . The method according to claim 181 , wherein the flow pathway comprises a diameter of less than 5.0 mm.

183 . The method according to claim 1 , further comprising placing an implant proximate the flow pathway.

184 . The method according to claim 183 , wherein the implant comprises a component selected from the group consisting of: anastomotic clip; suture; staple; adhesive; and combinations thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2019
From: ROX MEDICAL, INC.
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 051396/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2016
From: BRENNEMAN, RODNEY; BALMFORTH, PETER
To: ROX MEDICAL, INC.
Reel/Frame 038937/0447 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2016
From: FURNISS, STEVE
To: ROX MEDICAL, INC.
Reel/Frame 038937/0488 →